These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 13480236)

  • 21. The effect of LSD, mescaline, and D-amphetamine on the evoked "secondary discharge".
    Roth WT
    Psychopharmacologia; 1966; 9(3):253-8. PubMed ID: 6010545
    [No Abstract]   [Full Text] [Related]  

  • 22. Cross tolerance between mescaline and LSD-25, with a comparison of the mescaline and LSD reactions.
    WOLBACH AB; ISBELL H; MINER EJ
    Psychopharmacologia; 1962 Mar; 3():1-14. PubMed ID: 14007904
    [No Abstract]   [Full Text] [Related]  

  • 23. The cerebral electrographic changes induced by LSD and mescaline are corrected by frenquel.
    RINALDI F; HIMWICH HE
    J Nerv Ment Dis; 1955 Nov; 122(5):424-32. PubMed ID: 13320138
    [No Abstract]   [Full Text] [Related]  

  • 24. Tolerance to a behavioral effect of lysergic acid diethylamide and cross-tolerance to mescaline in the rat: absence of a metabolic component.
    Winter JC
    J Pharmacol Exp Ther; 1971 Sep; 178(3):625-30. PubMed ID: 5571911
    [No Abstract]   [Full Text] [Related]  

  • 25. LSD mescaline and serotonin injected into medial raphe nucleus potentiate apomorphine hypermotility.
    Fink H; Oelssner W
    Eur J Pharmacol; 1981 Nov; 75(4):289-96. PubMed ID: 7318915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of LSD and other hallucinogens with dopamine-sensitive adenylate cyclase in primate brain: regional differences.
    Ahn HS; Makman MH
    Brain Res; 1979 Feb; 162(1):77-88. PubMed ID: 104775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysergic acid diethylamide (LSD) as a discriminative cue: drugs with similar stimulus properties.
    Schechter MD; Rosecrans JA
    Psychopharmacologia; 1972; 26(3):313-6. PubMed ID: 5073050
    [No Abstract]   [Full Text] [Related]  

  • 28. Behavioural effects of some derivatives of amphetamine and LSD and their significance.
    Smythies JR; Beaton J; Benington F; Morin RD
    Nature; 1970 May; 226(5246):644-5. PubMed ID: 5444927
    [No Abstract]   [Full Text] [Related]  

  • 29. Cumulative alterations in rat behavior during continuous administration of LSD or mescaline: absence of tolerance?
    Ellison G; Ring M; Ross D; Axelrood B
    Biol Psychiatry; 1980 Feb; 15(1):95-102. PubMed ID: 7357060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Psilocybin, LSD, and mescaline on small, involuntary eye movements.
    Hebbard FW; Fischer R
    Psychopharmacologia; 1966; 9(2):146-56. PubMed ID: 5983913
    [No Abstract]   [Full Text] [Related]  

  • 31. Mescaline and LSD facilitate the activation of locus coeruleus neurons by peripheral stimuli.
    Aghajanian GK
    Brain Res; 1980 Mar; 186(2):492-8. PubMed ID: 7357465
    [No Abstract]   [Full Text] [Related]  

  • 32. Antidiuresis in man following lysergic acid diethylamide and mescaline.
    Hollister LE; Kanter SL; Dronkert A
    Behav Neuropsychiatry; 1970; 2(3):50-4. PubMed ID: 4913153
    [No Abstract]   [Full Text] [Related]  

  • 33. Psychoses-producing and psychoses-relieving drugs.
    HOCH PH
    Res Publ Assoc Res Nerv Ment Dis; 1958; 36():335-46. PubMed ID: 13527792
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of LSD-25 and mescaline on the electroplax of the electric eel.
    Webb GD; Farquharson DA
    Am J Physiol; 1971 Dec; 221(6):1802-8. PubMed ID: 4330905
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of intraocular mescaline and LSD on visual-evoked responses in the rat.
    Eells JT; Wilkison DM
    Pharmacol Biochem Behav; 1989 Jan; 32(1):191-6. PubMed ID: 2734330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of short time intervals under LSD25 and mescaline.
    Mitrani L; Shekerdjiiski S; Gourevitch A; Yanev S
    Act Nerv Super (Praha); 1977 May; 19(2):103-4. PubMed ID: 888639
    [No Abstract]   [Full Text] [Related]  

  • 37. Identification of time intervals under LSD25 and mescaline.
    Mitrani L; Shekerdjiiski S; Gurevich A; Yanev S
    C R Acad Bulg Sci; 1977; 30(11):1645-7. PubMed ID: 608407
    [No Abstract]   [Full Text] [Related]  

  • 38. A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist.
    Colpaert FC; Niemegeers CJ; Janssen PA
    J Pharmacol Exp Ther; 1982 Apr; 221(1):206-14. PubMed ID: 7062283
    [No Abstract]   [Full Text] [Related]  

  • 39. The preservation of substance P by lysergic acid diethylamide.
    KRIVOY WA
    Br J Pharmacol Chemother; 1957 Sep; 12(3):361-4. PubMed ID: 13460245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Critical study on taraxeine].
    Bury JA
    Encephale; 1969; 58(1):69-94. PubMed ID: 4989013
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.